Cubist Pharmaceuticals, Inc. (CBST) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts CBST Hot Sheet
Price: $101.94 --0%
Financial Fact:
Operating (loss) income: 67.81M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Operating (loss) income: 67.81M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reported Q1 EPS of $0.45, $0.01 better than the analyst estimate of $0.44. Revenue for the quarter came in at $211.7 million versus the consensus estimate of $210.54 million.
For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.
For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- Onemeta reports 500% usage rise and $2.4M cash flow in H1 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
